“Increased Plasma Caspase-3 in Children with Down Syndrome is Associated with an Increasing Risk of Pulmonary Hypertension”, J Matern Child Health, vol. 8, no. 1, pp. 23–32, Jan. 2023, doi: 10.26911/thejmch.2023.08.01.03.